Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00543907 · ClinicalTrials.gov registry record

Outcomes of a Deep Inferior Epigastric Perforator Flap Program

A clinical trial of Breast Cancer, sponsored by Beth Israel Deaconess Medical Center.

Completed
Registry status
977
Enrollment target
1
Study location

NCT00543907 is a study of Breast Cancer that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 977 participants, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00543907, a study of Breast Cancer, has completed, sponsored by Beth Israel Deaconess Medical Center.

COMPLETED
Registry status
977 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to analyze an institution's experience with starting a subspecialized DIEP flap program.

Conditions Studied

Study Locations (1)

Massachusetts

  • Beth Israel Deaconess Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 977 participants
Start Date 2007-09
Est. Completion 2008-12

What the Registry Record Tells You About NCT00543907

The ClinicalTrials.gov registry entry for NCT00543907 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 977 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (65% lower). The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 0 interventions.

NCT00543907 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00543907 about?

NCT00543907 is a clinical study titled "Outcomes of a Deep Inferior Epigastric Perforator Flap Program". The purpose of this study is to analyze an institution's experience with starting a subspecialized DIEP flap program.

What is the current status of trial NCT00543907?

This trial is currently completed. The enrollment target is 977 participants. The study started on 2007-09. Estimated completion is 2008-12.

What conditions does trial NCT00543907 study?

This clinical trial studies the following conditions: Breast Cancer.

Who is sponsoring clinical trial NCT00543907?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00543907 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.